Heartflow, Inc. Common Stock
HTFL
Classificação em ações
#3568
HeartFlow, Inc. operates as a global medical technology firm, specializing in... HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
Preço da ação
$55.33
Última sincronização: 2026-10-20
Valor de mercado
$4.81B
Variação (1 dia)
8.44%
Variação (1 ano)
51.00%
País
US
Negociar Heartflow, Inc. Common Stock (HTFL)
Categoria
Healthcare
Lucros da Heartflow, Inc. Common Stock (HTFL)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Heartflow, Inc. Common Stock, os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Heartflow, Inc. Common Stock de 2026 a 2026
Lucros no final de cada ano
| Ano | Lucros | Alterar |
|---|---|---|
| Não há dados suficientes para as datas fornecidas. | ||
Lucros de empresas semelhantes ou concorrentes
| Empresa | Lucros | Diferença de Lucros | País |
|---|---|---|---|
| $2.04B | - |
US
|
|
| $266.26M | - |
AU
|
|
| $295.53M | - |
US
|
|
| $-259.89M | - |
US
|
|
| $-74.89M | - |
US
|
